ChromaDex (CDXC) Earnings growth forecast for next year

Corporate company logo of ChromaDex Corp. (CDXC)

ChromaDex Corporation (CDXC) is expanding global distribution through B2B contracts, confirming the earnings per share growth trend on the GURU.Markets system chart, where the 57.40 metric determines this level. Financial stability is based on patent licensing for third-party brands and the recruitment of top biochemists through premium payments and stock options.

ChromaDex Corp (CDXC): Expected earnings per share trend next year from 07/04/2022 to 03/19/2025

Analytical breakdowns for ChromaDex Corporation

- share price and consensus valuation forecast:
Basic company analysis:ChromaDex Corp, CDXC
Core merchandise of ChromaDex

This indicator measures the expected percentage growth in earnings per share, reflecting the market consensus regarding future business efficiency. By analyzing the consensus estimate of net profit growth rates, an investor can see the projected return, which for ChromaDex Corporation (CDXC) depends directly on the stability of B2B contracts for the supply of Tru Niagen components into global dietary supplement production chains.